Amgen ends marketing agreement with GSK for osteoporosis drug

[riky]

Amgen ends marketing agreement with GSK for osteoporosis drug

<p><a href="http://news.yahoo.com/amgen-ends-marketing-agreement-gsk-osteoporosis-drug-140016622--finance.html"><img src="http://l2.yimg.com/bt/api/res/1.2/LWE6mT4tnIf9eiHVxj3Ujw--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9NzU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2014-04-03T154326Z_1_CBREA3217OJ00_RTROPTP_2_LUXEMBOURG.JPG" width="130" height="86" alt="The GlaxoSmithKline logo is seen at the entrance of a building in Luxembourg" align="left" title="The GlaxoSmithKline logo is seen at the entrance of a building in Luxembourg" border="0" /></a>(Reuters) - Amgen Inc said it would end an agreement with GlaxoSmithKline Plc for the marketing of its osteoporosis drug in some regions outside the United States. Amgen said it would take over the marketing of the drug, sold under the brand name Prolia, in most areas under the agreement, including the European Union, Switzerland, Norway, Russia and Mexico, by December 31. GSK will continue to market the drug in Australia, Amgen said in a regulatory filing.</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login